Report Date: Wednesday, July 29, 2026 | Event: 2026Q2 Earnings Call
Bunge enters tomorrow's print with a stock that has been volatile but broadly strong in 2026 — shares ran from roughly $93 in early January to a peak near $131 in early June, sold off to about $107 by June 30, and have since recovered to the $117-118 range heading into earnings. The move higher this year has been driven largely by strengthening crush economics tied to biofuel policy clarity and, more recently, energy-market disruption from the Middle East conflict pushing up diesel and soybean-oil prices.
Sell-side sentiment is constructive: consensus rating is Buy/Strong Buy, with price targets ranging roughly from the low $110s to $150 and averages in the low-to-mid $140s. Barclays has an Overweight with a Street-high $150 target, and BofA has moved its target up to $130. Consensus estimates for the quarter are running around $23.5 billion in revenue and roughly $2.03 in adjusted EPS, reflecting expectations of strong year-over-year growth off last year's Viterra-inflated but margin-challenged base.
Bunge's first quarter was a blowout relative to expectations. Adjusted EPS of $1.83 was roughly flat year-over-year (vs. $1.81), but well ahead of the low-$0.80s the company had originally guided to, driven by outperformance in Soybean and Softseed Processing and Refining. Management responded by raising full-year adjusted EPS guidance materially — from $7.50–$8.00 up to $9.00–$9.50 — citing "the current margin and macro environment and forward curves." Segment-level, the company said Soybean and Softseed Processing/Refining results are expected to be higher than prior guidance, while Tropical Oils and Specialty Ingredients and Grain Merchandising and Milling were guided lower, with Corporate and Other in line.
Management also gave explicit cadence guidance on the Q1 call: full-year earnings are now expected to skew 40% first half / 60% second half (versus 30/70 previously), with Q3/Q4 roughly 45%/55%. Applying that math to the new $9.00–$9.50 range implies first-half EPS of about $3.60–$3.80, meaning Q2 adjusted EPS should fall in roughly the $1.77–$1.97 range on a straight-line basis — modestly below the ~$2.03 Street consensus, which would suggest the market is pricing in incremental upside from the stronger crush environment seen through Q2.
At Bunge's March Investor Day, management raised its 2030 mid-cycle EPS baseline to over $15, up from $13 previously discussed and $7–$8.50 pre-Viterra, driven by three "controllable" levers worth roughly $5/share combined: completion of large in-flight CapEx projects (~$1.30/share), Viterra cost and commercial synergies, and disciplined capital allocation/buybacks. Cost synergies were raised to roughly $350 million (from an original $250 million target), with commercial synergies of $250–$300 million also identified — and management indicated the Q1 print already reflects Viterra cost synergies "running ahead of plan." Investors should listen for an update on synergy capture pace, plus commentary on the Renova plant (the world's largest crush facility, acquired via Viterra) and grain-merchandising network synergies, which management called the hardest segment to forecast but the area with the most synergy upside.
Bunge heads into Q2 with fresh, sharply raised guidance, a Viterra integration that management says is ahead of plan, and a favorable (if volatile) crush-margin backdrop tied to biofuel policy and geopolitically-driven energy prices. The setup is a high bar: consensus EPS (~$2.03) sits slightly above the company's own implied Q2 run-rate (~$1.77–$1.97), so the print likely hinges on whether continued crush strength and merchandising/Argentina outperformance — the same drivers that fueled Q1's beat — can offset guided headwinds in Grain Merchandising, Tropical Oils, taxes, and interest expense. With Street price targets well above the current share price and a Buy-skewed analyst base, the market appears to be underwriting further upside from synergy capture and mid-cycle margin normalization; any disappointment on the softer segments or a more cautious tone on second-half visibility (curves remain notably inverted, per management's own Q1 commentary) would be the key risk to watch.